PT76147A - Process for the preparation of pyrazolooxazines pyrazolothiazines and pyrazoloquinolines with a lipoxygenase inhibiting effect and their use for the preparation of pharmaceutical compositions having a lipoxygenase inhibiting effect - Google Patents

Process for the preparation of pyrazolooxazines pyrazolothiazines and pyrazoloquinolines with a lipoxygenase inhibiting effect and their use for the preparation of pharmaceutical compositions having a lipoxygenase inhibiting effect

Info

Publication number
PT76147A
PT76147A PT76147A PT7614783A PT76147A PT 76147 A PT76147 A PT 76147A PT 76147 A PT76147 A PT 76147A PT 7614783 A PT7614783 A PT 7614783A PT 76147 A PT76147 A PT 76147A
Authority
PT
Portugal
Prior art keywords
preparation
inhibiting effect
lipoxygenase inhibiting
pyrazolothiazines
pyrazolooxazines
Prior art date
Application number
PT76147A
Other languages
English (en)
Portuguese (pt)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PT76147A publication Critical patent/PT76147A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT76147A 1982-02-06 1983-01-27 Process for the preparation of pyrazolooxazines pyrazolothiazines and pyrazoloquinolines with a lipoxygenase inhibiting effect and their use for the preparation of pharmaceutical compositions having a lipoxygenase inhibiting effect PT76147A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823204126 DE3204126A1 (de) 1982-02-06 1982-02-06 Pyrazoloxazine, -thiazine, -chinoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
PT76147A true PT76147A (en) 1983-02-01

Family

ID=6154989

Family Applications (1)

Application Number Title Priority Date Filing Date
PT76147A PT76147A (en) 1982-02-06 1983-01-27 Process for the preparation of pyrazolooxazines pyrazolothiazines and pyrazoloquinolines with a lipoxygenase inhibiting effect and their use for the preparation of pharmaceutical compositions having a lipoxygenase inhibiting effect

Country Status (16)

Country Link
US (1) US4552874A (forum.php)
EP (1) EP0085881A3 (forum.php)
JP (1) JPS58146583A (forum.php)
KR (1) KR840003641A (forum.php)
AU (1) AU1112583A (forum.php)
DE (1) DE3204126A1 (forum.php)
DK (1) DK49283A (forum.php)
ES (1) ES8402591A1 (forum.php)
FI (1) FI830378L (forum.php)
GR (1) GR77960B (forum.php)
HU (1) HU190063B (forum.php)
IE (1) IE830227L (forum.php)
IL (1) IL67826A0 (forum.php)
NO (1) NO830236L (forum.php)
PT (1) PT76147A (forum.php)
ZA (1) ZA83743B (forum.php)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO834401L (no) * 1982-12-14 1984-06-15 Troponwerke Gmbh & Co Kg Pyrazolo(4.3-b)(1.4)oxasiner, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel
ES8602818A1 (es) * 1983-10-31 1985-12-01 Merck Frosst Canada Inc Una composicion farmaceutica
US4749699A (en) * 1983-10-31 1988-06-07 Merck Frosst Canada, Inc. 5-lipoxygenease inhibitors
US4634766A (en) * 1983-10-31 1987-01-06 Merck Frosst Canada, Inc. 1,4-diaza-phenothiazines
US5756747A (en) * 1989-02-27 1998-05-26 Riker Laboratories, Inc. 1H-imidazo 4,5-c!quinolin-4-amines
US5037986A (en) * 1989-03-23 1991-08-06 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo[4,5-c]quinolin-4-amines
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
US5116837A (en) * 1990-12-21 1992-05-26 Ortho Pharmaceutical Corporation 2,9-dihydro-(6 or 7)-(3-oxo-2,3,4,5-tetrahydropyridazinyl)-pyrazolo [4,3-B]-1,4-benzoxazines
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
DE4122035A1 (de) * 1991-07-03 1993-01-07 Henkel Kgaa Die verwendung von 1,9-dihydro-pyrazolo(4,3-b) (1,4)-benzoxazinen als kuppler fuer oxidationsfaerbemittel
US5608067A (en) * 1993-12-09 1997-03-04 Afonso; Adriano 4-substituted pyrazoloquinoline derivatives
US5786480A (en) * 1994-04-28 1998-07-28 Schering Corporation 4-substituted pyrazoloquinoline derivatives
US6008218A (en) * 1995-12-08 1999-12-28 Ube Industries, Ltd. N-phenyl carbamate compounds, process for producing the same, and agricultural or horticultural bactericides
BRPI0413558A (pt) 2003-08-12 2006-10-17 3M Innovative Properties Co compostos contendo imidazo substituìdo por hidroxilamina
US7897597B2 (en) 2003-08-27 2011-03-01 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
CA2537763A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
AR046046A1 (es) 2003-10-03 2005-11-23 3M Innovative Properties Co Imidazoquinolinas alcoxi sustituidas. composiciones farmaceuticas.
JP2007511527A (ja) 2003-11-14 2007-05-10 スリーエム イノベイティブ プロパティズ カンパニー オキシム置換イミダゾ環化合物
WO2005048945A2 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
WO2005051317A2 (en) 2003-11-25 2005-06-09 3M Innovative Properties Company Substituted imidazo ring systems and methods
JP2007517035A (ja) 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
JP2007517044A (ja) 2003-12-30 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー イミダゾキノリニル、イミダゾピリジニル、およびイミダゾナフチリジニルスルホンアミド
AU2005228150A1 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006083440A2 (en) 2004-12-30 2006-08-10 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
US7943609B2 (en) 2004-12-30 2011-05-17 3M Innovative Proprerties Company Chiral fused [1,2]imidazo[4,5-C] ring compounds
WO2006084251A2 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
US7968563B2 (en) 2005-02-11 2011-06-28 3M Innovative Properties Company Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
US7943610B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company Pyrazolopyridine-1,4-diamines and analogs thereof
US7943636B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
EP2166853B1 (en) * 2007-06-08 2014-05-28 Dart Neuroscience (Cayman) Ltd Therapeutic pyrazolonaphthyridine derivatives
WO2008154442A1 (en) * 2007-06-08 2008-12-18 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline urea derivatives
KR20100039331A (ko) * 2007-06-08 2010-04-15 헬리콘 테라퓨틱스 인코퍼레이티드 치료용 피라졸로퀴놀린 유도체

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3790576A (en) * 1972-03-20 1974-02-05 Parke Davis & Co 9 substituted 4,9-dihydro-1,3,4,4-tetraalkyl-1h-pyrazolo(3,4-b)quinolines

Also Published As

Publication number Publication date
FI830378A7 (fi) 1983-08-07
DK49283D0 (da) 1983-02-04
DE3204126A1 (de) 1983-08-11
GR77960B (forum.php) 1984-09-25
KR840003641A (ko) 1984-09-15
EP0085881A3 (de) 1984-03-07
IE830227L (en) 1983-08-06
EP0085881A2 (de) 1983-08-17
ES519559A0 (es) 1984-02-01
HU190063B (en) 1986-08-28
NO830236L (no) 1983-08-08
FI830378L (fi) 1983-08-07
US4552874A (en) 1985-11-12
ES8402591A1 (es) 1984-02-01
AU1112583A (en) 1983-08-11
IL67826A0 (en) 1983-06-15
ZA83743B (en) 1983-11-30
JPS58146583A (ja) 1983-09-01
FI830378A0 (fi) 1983-02-03
DK49283A (da) 1983-08-07

Similar Documents

Publication Publication Date Title
PT76147A (en) Process for the preparation of pyrazolooxazines pyrazolothiazines and pyrazoloquinolines with a lipoxygenase inhibiting effect and their use for the preparation of pharmaceutical compositions having a lipoxygenase inhibiting effect
GB2103591B (en) Pharmaceutical compositions and process
IL60095A0 (en) Pharmaceutical compositions comprising nalbuphine and acetaminophen
DE3363472D1 (en) Process for the preparation of n-substituted n-cyano-amides and their use
DE3071101D1 (en) Antimycotic synergistic pharmaceutical compositions and process for the preparation thereof
PH16443A (en) Substituted tetraazetricyclic compounds and their pharmaceutical compositions
PT76657A (en) Process for preparing 4-aryl-4-piperidinecarbinols and of pharmaceutical compositions containing the same
PT77217A (en) Process for preparing 3-phenoxy-1-azetidine-carboxamides and of pharmaceutical compositions containing the same
PT77097B (en) Process for the preparation of 4h-1,4-curied benzothiazines having a lipoxygenase inhibition effect and their application for the preparation of pharmaceutical compositions having a lipoxygenase inhibition effect
PT79858A (en) Process for the preparation of azolyl-aryl-alcanol and pharmaceutical compositions therewith
IL61117A (en) 2beta-acetoxymethyl-penam compounds and pharmaceutical compositions containing them
DE3379534D1 (en) Pharmaceutical compositions for the treatment of arthrosis deformans
PT75042B (en) Process for the preparation of apovincaminates and pharmaceutical compositions containing them
GB2050833B (en) Pharmaceutical compositions and process for the preparation thereof
DE3277171D1 (en) Pharmaceutical composition and the use of sn- or cr-protoporphyrin for the manufacture thereof
NZ189899A (en) Dilignols and dilignol-type compounds pharmaceutical compositions
DE3362340D1 (en) A pharmaceutical composition and the use thereof for the treatment of inflammation
ZA832811B (en) Azabicyclobenzamides their preparation and their pharmaceutical compositions
PT75613B (en) Process for the preparation of carboxamid-thiol-carbamate deri-vatives and herbicide compositions thereof
PT71885A (en) Process for the preparation of ergot-peptide alkaloides having pharmaceutical effect
PT76389A (en) Process for the preparation of 7-alpha-aminoacyl-3-chlorocepha-losporins having and anti-infections effect and their use for the preparation of pharmaceutical compositions having an anti-infections effect
ZA834539B (en) Pharmaceutical composition and its preparation and use
ZA814056B (en) Pharmaceutical bicyclo-octatriene compounds and compositions
PT79990A (en) Process for the preparation of diazepine-indoles and of pharmaceutical compositions therewith
PT76753B (en) Process for the preparation of alkylene-bis-heterocyclyl-biguanides and/or cycloalkylene-bis-heterocyclyl-biguanides having a fungicidal effect